Shares of Covid vaccine makers skyrocket on Omicron variant concerns

moderna (MRNA) increased more over 20% during Black Friday’s abbreviated session of trading on Wall Street and wares up another 10% on Monday too.
BioNTech (BNTX) rose Friday met 14% and were up 3% Monday as European drugmaker’s vaccine partner, the leader of Big Pharma Pfizer (PFE), won Friday 6%, but fell a bit on Monday.
Shares of Novavax (NVAX), another company that is seek approval from the US Food and Drug Administration for his Covid vaccine, were up 9% Friday but gave back An big chunk of die gains Monday, down 8%.
the stock of two other vaccine manufacturers — Johnson & Johnson (JNJ) and AstraZeneca (AZNO) — moved only modestly Friday and Monday.
The variant of the Omicron coronavirus is a crucial test for    Biden

Investors hope the big vaccine makers can quickly update their Covid vaccines so it can provide protection for the Omicron variant.

moderna said friday that it will “promptly promote an Omicron-specific booster candidate,” while Pfizer has emphasized that it can hopefully Have a update of the vaccine is ready in 100 days if Omicron proves to be resistant to its current vaccine.

Read More: World News


Denial of any Responsibility!
AsumeTech is a News Source that Publishes News from its Editorial Team and the Automatic News Aggregation around the News Media. All the Aggregated Content you find on our site is available freely over the Internet; each piece of Content includes the hyperlink to its Primary Source. We have just arranged that in our platform for Educational Purposes only. All the Copyrights and Trademarks belong to their Rightful Owners and all Materials to their Authors. If you are the Content owner and do not want us to publish your materials on our Website, please get in touch with us by email – [email protected]; we will remove the Content from our Website.